Standardizing HIPEC and perioperative care for patients with ovarian cancer in the Netherlands using a Delphi-based consensus

Ruby M. van Stein(The Netherlands Cancer Institute), Willemien J. van Driel(The Netherlands Cancer Institute), Christianne Lok(The Netherlands Cancer Institute), Gabe S. Sonke(Oncode Institute), Aletta P. I. Houwink(Amsterdam Neuroscience), Herman Stoevelaar(Barnes-Jewish Hospital), Ignace H. J. T. de Hingh(Radboud University Nijmegen), Arend G. J. Aalbers(The Netherlands Cancer Institute)
Gynecologic Oncology Reports
February 1, 2022
10.1016/j.gore.2022.100945
Cited by 18

Related Papers

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Effect of Low-Intensity Physical Activity and Moderate- to High-Intensity Physical Exercise During Adjuvant Chemotherapy on Physical Fitness, Fatigue, and Chemotherapy Completion Rates: Results of the PACES Randomized Clinical Trial
|Journal of Clinical Oncology|2015|655
Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs
|Cancer Treatment Reviews|2016|616